Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors
(NASDAQ: LPTX) Delayed: 2.06 --0 (-0%)
Previous Close $2.06    52 Week High $ 
Open $2.06    52 Week Low $ 
Day High $2.06    P/E N/A 
Day Low $2.06    EPS $ 
Volume 1,000       

(NASDAQ: LPTX) Delayed: 2.06 --0 (-0%)
Previous Close $2.06    52 Week High $ 
Open $2.06    52 Week Low $ 
Day High $2.06    P/E N/A 
Day Low $2.06    EPS $ 
Volume 1,000